• Trinity Delta Futura Medical Significant achievements position MED3000 for success

    September 2023

  • Trinity Delta Futura Medical Haleon to commercialise MED3000 in the US

    July 2023

  • Trinity Delta Futura Medical Key takeaways from Investor Seminar

    June 2023

  • Trinity Delta Futura Medical First months of Eroxon launch suggest a successful start

    June 2023

  • Trinity Delta Futura Medical MED3000 FDA clearance marks a major step in the US

    June 2023

  • Trinity Delta Futura Medical Gearing up for further launches in 2023

    April 2023

  • Trinity Delta Futura Medical MED3000 soft launch in Europe , FDA approval now Q2

    March 2023

  • Trinity Delta Futura Medical MED3000 continues to progress towards first sales

    December 2022

  • Trinity Delta Futura Medical On The Cusp of MED3000 Commercialisation

    November 2022

  • Trinity Delta Futura Medical Interims highlight positive first signs in key markets

  • Trinity Delta Futura Medical FM71 achieves all primary and secondary endpoints

  • Trinity Delta Futura Medical Major MED3000 deal for Europe with Cooper Health

  • Trinity Delta Futura Medical FY21 results reassure on cash runway and hint at EU deal

  • Trinity Delta Futura Medical Menarini to commercialise MED3000 in South Korea

  • Trinity Delta Futura Medical : A Year of delivery , with key milestones achieved

  • Trinity Delta Futura Medical Raising £12m through £10m placing and £2m retail offer

  • Trinity Delta Futura Medical MED3000 receives CE Mark as a Class II(b) device

  • Trinity Delta Futura Medical FY21 is set to be a year of execution

  • Trinity Delta Futura Medical EU Notified Body recommends MED3000 approval

    Futura Medical EU Notified Body recommends MED3000 approval

  • Trinity Delta Futura Medical Commercialisation deal for China and SE Asia

    Commercialisation deal for China and SE Asia

  • Trinity Delta Futura Medical Lighthouse

    MED3000 FDA details the scope of confirmatory study


  • Trinity Delta Futura Medical MED3000 on course for OTC approval in Europe and US

    MED3000 on course for OTC approval in Europe and US


  • Trinity Delta FDA green lights MED3000 for OTC approval

    FDA green lights MED3000 for OTC approval


  • Trinity Delta Futura Medical Outlook

    Nearing the critical point in Erectile Dysfunction


  • Trinity Delta details more on FM57 Results

    MED3000: more detail on FM57 results


  • Trinity Delta details FY19 results and MED3000 update

    Encouraging FY19 results and MED3000 update


  • Trinity Delta details of the MED3000 European regulatory pathway

    MED3000 European regulatory pathway is clearer


  • Trinity Delta Initiates Coverage

    Initiation of Coverage